Protective efficacy evaluation induced by recombinant protein LHD-Sj23-GST of Schistosoma japonicum emulsified with three different adjuvants

Parasite Immunology

Volumn 34, Issue 6, 2012, Pages 341-344

  Zhu, Z ^a,b   Fu, Z ^a   Zhang, M ^a   Han, Y ^a,b   Hong, Y ^a,b   Li, D ^a   Zhao, Z ^a   Shi, Y ^a   Li, X ^b   Lin, J ^a  

^a AGRO ENVIRONMENTAL PROTECTION INSTITUTE   (China)

^b NANJING AGRICULTURAL UNIVERSITY   (China)

Author keywords

Adjuvant; Protective immunity; Recombinant LHD Sj23 GST; Schistosomiasis japonica

Indexed keywords

EMULSIFYING AGENT; FREUND ADJUVANT; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOGLOBULIN G3 ANTIBODY; MONTANIDE ISA 206; MONTANIDE ISA 70M; RECOMBINANT LARGE HYDROPHILIC DOMAIN SCHISTOSOMA JAPONICUM ANTIGEN 23KDA GLUTATHIONE TRANSFERASE FUSION PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ADJUVANT CHEMOTHERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CERCARIA; CONTROLLED STUDY; DRUG EFFICACY; EMULSION; ENZYME LINKED IMMUNOSORBENT ASSAY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; TREATMENT RESPONSE; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; CHINA; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOGLOBULIN G; MICE; PARASITE LOAD; RECOMBINANT FUSION PROTEINS; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; VACCINATION; VACCINES, SYNTHETIC;

JAPONICA; MUS; SCHISTOSOMA; SCHISTOSOMA JAPONICUM;

EID: 84860893239     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2012.01357.x     Document Type: Article

References (13)

1. van dWM, de VS, Brooker S, et al. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop 2003; 86: 125-139.
2. Steinmann P, Keiser J, Bos R, Tanner M & Utzinger J. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 2006; 6: 411-425.
3. Shi F, Zhang Y, Ye P, et al. Laboratory and field evaluation of Schistosoma japonicum DNA vaccines in sheep and water buffalo in China. Vaccine 2001; 20: 462-467.
4. Shi F, Zhang Y, Lin J, et al. Field testing of Schistosoma japonicum DNA vaccines in cattle in China. Vaccine 2002; 20: 3629-3631.
5. Dupre L, Kremer L, Wolowczuk I, Riveau G, Capron A & Locht C. Immunostimulatory effect of IL-18-encoding plasmid in DNA vaccination against murine Schistosoma mansoni infection. Vaccine 2001; 19: 1373-1380.
6. Tylor MG, Huggins MC, Shi F, et al. Production and testing of Schistosoma japonicum candidate vaccine antigens in the natural ovine host. Vaccine, 1998; 16(13): 1290-1298.
7. Dupuis L, Ascarateil S, Aucouturier J & Ganne V. SEPPIC vaccine adjuvants for poultry. Ann N Y Acad Sci 2006; 1081: 202-205.
8. Leenaars PP, Koedam MA, Wester PW, Baumans V, Claassen E & Hendriksen CF. Assessment of side effects induced by injection of different adjuvant/antigen combinations in rabbits and mice. Lab Anim 1998; 32: 387-406.
9. Aucouturier J, Dupuis L & Ganne V. Adjuvants designed for veterinary and human vaccines. Vaccine 2001; 19: 2666-2672.
10. Unkeless JC, Scigliano E & Freedman VH. Structure and function of human and murine receptors for IgG. Annu Rev Immunol 1988; 6: 251-281.
11. Maizels RM & Yazdanbakhsh M. Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat Rev Immunol 2003; 3: 733-744.
12. Fu ZQ, Liu JM, Jiang SF, et al. Observation and analysis of Schistosoma japonicum specific antibodies in sera of Microtus fortis. Chinese J Vet Parasitol 2001; 9: 6-9.
13. Wu Z, Liu S, Zhang S, et al. Persistence of the protective immunity to Schistosoma japonicum in Chinese yellow cattle induced by recombinant 26kDa glutathione-S-transferase (reSjc26GST). Vet Parasitol 2004; 123: 167-177.